Genomic Health Q4 Revenues Climb 14 Percent as It Targets Prostate Cancer, International Markets for Growth | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health said after the close of the market on Tuesday that its revenues in the fourth quarter increased 14 percent year over year.

Total revenues for the three months ended Dec. 31, 2013 came in at $68.8 million, up from $60.4 million, but short of the average analyst estimate of $69.2 million. Product revenues rose 12 percent to $67.1 million from $60 million, while contract revenues rose more than four-fold to $1.8 million from $429,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.